BACKGROUND: Electronic cigarette (e-cigarette) vapour is gaining popularity as an alternative to tobacco smoking and can induce acute lung injury. However, the specific role of nicotine in e-cigarette vapour and its long-term effects on the airways, lung parenchyma and vasculature remain unclear. RESULTS: In vitro exposure to nicotine-containing e-cigarette vapour extract (ECVE) or to nicotine-free e-cigarette vapour extract (NF ECVE) induced changes in gene expression of epithelial cells and pulmonary arterial smooth muscle cells (PASMCs), but ECVE in particular caused functional alterations (e.g. a decrease in human and mouse PASMC proliferation by 29.3±5.3% and 44.3±8.4%, respectively). Additionally, acute inhalation of nicotine-containing e-cigarette vapour (ECV) but not nicotine-free e-cigarette vapour (NF ECV) increased pulmonary endothelial permeability in isolated lungs. Long-term in vivo exposure of mice to ECV for 8 months significantly increased the number of inflammatory cells, in particular lymphocytes, compared to control and NF ECV in the bronchoalveolar fluid (BALF) (ECV: 853.4±150.8 cells·mL(-1); control: 37.0±21.1 cells·mL(-1); NF ECV: 198.6±94.9 cells·mL(-1)) and in lung tissue (ECV: 25.7±3.3 cells·mm(-3); control: 4.8±1.1 cells·mm(-3); NF ECV: 14.1±2.2 cells·mm(-3)). BALF cytokines were predominantly increased by ECV. Moreover, ECV caused significant changes in lung structure and function (e.g. increase in airspace by 17.5±1.4% compared to control), similar to mild tobacco smoke-induced alterations, which also could be detected in the NF ECV group, albeit to a lesser degree. In contrast, the pulmonary vasculature was not significantly affected by ECV or NF ECV. CONCLUSIONS: NF ECV components induce cell type-specific effects and mild pulmonary alterations, while inclusion of nicotine induces significant endothelial damage, inflammation and parenchymal alterations.
- Roxlau, E. T.
- Pak, O.
- Hadzic, S.
- Garcia-Castro, C. F.
- Gredic, M.
- Wu, C. Y.
- Schäffer, J.
- Selvakumar, B.
- Pichl, A.
- Spiegelberg, D.
- Deutscher, J.
- Bednorz, M.
- Schäfer, K.
- Kraut, S.
- Kosanovic, D.
- Zeidan, E. M.
- Kojonazarov, B.
- Herold, S.
- Strielkov, I.
- Guenther, A.
- Wilhelm, J.
- Khalifa, M. M. A.
- Taye, A.
- Brandes, R. P.
- Hecker, M.
- Grimminger, F.
- Ghofrani, H. A.
- Schermuly, R. T.
- Seeger, W.
- Sommer, N.
- Weissmann, N.
Keywords
- Humans
- Animals
- Mice
- Nicotine/adverse effects
- *Electronic Nicotine Delivery Systems
- *E-Cigarette Vapor/adverse effects/metabolism
- *Pneumonia/etiology/metabolism
- Lung/metabolism
- Plant Extracts/metabolism/pharmacology